Kunming Longjin Pharmaceutical Co.,Ltd. Posted 73.5 Million Yuan Net Loss in 2022

Kunming Longjin Pharmaceutical Co.,Ltd. (昆明龙津药业股份有限公司) (002750.SZ) reported a net loss of 73.5 million yuan in 2022, widening 885.6% year-on-year.

Meanwhile, the company posted 123 million yuan in revenue, down 82.5% year-on-year.

At the end of the reporting period, it had 747.2 million yuan in total assets and 142.4 million yuan in total liabilities, with a liability-to-asset ratio of 19.1%.